NSE · SUNPHARMA.NS
Sun Pharmaceutical Industries Limited
₹1,802.20+₹41.20 (+2.34%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 11.96% below the high.
Loading market information…
NSE · VALIANTLAB.NS · INR
Stock price
Quote as of Oct 30, 2026, 07:44 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Valiant Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 9.23% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Valiant Laboratories Limited, an India-based company, specializes in the production of active pharmaceutical ingredients (APIs) and bulk drugs, serving both domestic and international markets. Its primary product is paracetamol, manufactured in various grades that meet Indian, British, European, and United States pharmacopoeia standards. This crucial compound is utilized in treatments for common ailments such as headaches, muscle aches, arthritis, backaches, toothaches, colds, and fever. Beyond pharmaceuticals, the company also supplies specialty chemicals. Originally established in 1980 and headquartered in Mumbai, India, the firm rebranded as Valiant Laboratories Limited in August 2021, having previously operated under the name Bharat Chemicals. It functions as a subsidiary of Dhanvallabh Ventures LLP.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:10 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹1,802.20+₹41.20 (+2.34%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 11.96% below the high.
₹9,733.50+₹69.50 (+0.72%)
Divi's Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 1.12% below the high.
₹456.00-₹1.00 (-0.22%)
Bafna Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 4.99% below the high.
₹136.00-₹0.54 (-0.4%)
ZIM Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 14.9% below the high.
₹1,299.00+₹10.50 (+0.81%)
SMS Lifesciences India Limited’s quoted price sits in the lower half of its reported 52-week range, 22.68% below the high.
₹10.18-₹0.15 (-1.45%)
Nectar Lifesciences Limited’s quoted price sits in the lower half of its reported 52-week range, 54.55% below the high.
₹62.16-₹1.68 (-2.63%)
Brooks Laboratories Limited’s quoted price sits in the lower half of its reported 52-week range, 46.41% below the high.
₹18.61-₹0.37 (-1.95%)
Medico Remedies Limited’s quoted price sits in the lower half of its reported 52-week range, 67.28% below the high.
